Follow
Ann E. Hickox
Ann E. Hickox
Akouos, Inc.
Verified email at alum.mit.edu
Title
Cited by
Cited by
Year
Is noise-induced cochlear neuropathy key to the generation of hyperacusis or tinnitus?
AE Hickox, MC Liberman
Journal of Neurophysiology, 2014
3492014
Auditory Brainstem Response Latency in Noise as a Marker of Cochlear Synaptopathy
G Mehraei, AE Hickox, HM Bharadwaj, H Goldberg, S Verhulst, ...
The Journal of Neuroscience 36 (13), 3755-3764, 2016
2302016
Translational issues in cochlear synaptopathy
AE Hickox, E Larsen, MG Heinz, L Shinobu, JP Whitton
Hearing research 349, 164-171, 2017
1542017
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation
JR Gehlhausen, SJ Park, AE Hickox, M Shew, K Staser, SD Rhodes, ...
Human molecular genetics 24 (1), 1-8, 2015
762015
Global Analysis of Protein Expression of Inner Ear Hair Cells
AE Hickox, ACY Wong, K Pak, C Strojny, M Ramirez, JR Yates, AF Ryan, ...
Journal of Neuroscience 37 (5), 1320-1339, 2017
562017
Divergent auditory-nerve encoding deficits between two common etiologies of sensorineural hearing loss
KS Henry, M Sayles, AE Hickox, MG Heinz
Journal of Neuroscience, 2019
292019
Loss of LDAH associated with prostate cancer and hearing loss
BB Currall, M Chen, RC Sallari, M Cotter, KE Wong, NG Robertson, ...
Human Molecular Genetics, 2018
172018
Loudness Perception of Pure Tones in Parkinson's Disease
D Abur, AA Lupiani, AE Hickox, BG Shinn-Cunningham, CE Stepp
Journal of Speech, Language, and Hearing Research 61 (6), 1487-1496, 2018
122018
Genetic Medicine for Hearing Loss: OTOF as Exemplar
AE Hickox, MD Valero, JT McLaughlin, GS Robinson, JA Wellman, ...
Journal of the American Academy of Audiology 32 (10), 646-653, 2021
22021
Nonclinical In Vivo Expression, Durability of Effect, Biodistribution/Shedding, and Safety Evaluations Support Clinical Development of AK-OTOF (AAVAnc80-hOTOF Vector) for OTOF …
AE Hickox, Y Gao, SP Francis, Y Asai, R Ng, H Chiang, E Andres-Mateos, ...
MOLECULAR THERAPY 30 (4), 575-575, 2022
2022
Demonstration of Tolerability of a Novel Delivery Approach and Secreted Protein Expression Following Intracochlear Delivery of AK-antiVEGF (AAVAnc80-antiVEGF Vector) in Non …
J Connelly, IK Hughes, AE Hickox, SP Francis, CA Shera, A Salt, ...
MOLECULAR THERAPY 29 (4), 177-177, 2021
2021
Durable Recovery of Auditory Function Following Intracochlear Delivery of AK-OTOF (AAVAnc80-hOTOF Vector) in a Translationally Relevant Mouse Model of Otoferlin Gene (OTOF …
AE Hickox, Y Gao, F Yu, Y Darcy, K Reape, SP Francis, YH Kim, S Davis, ...
MOLECULAR THERAPY 29 (4), 276-277, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–12